ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,279Medicare Part D Prescriptions Filled, Including Refills

Rank: 100 out of 2604

$649K Total Retail Price of All Prescriptions

Rank: 98 out of 2604

254 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
93% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 254 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

19% of this provider’s 254 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

1% of this provider’s 9,023 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$63 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

40 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
SIMVASTATIN 451 406 1 2
METOPROLOL TARTRATE 448 399 2 9
LISINOPRIL 383 359 3 3
AMLODIPINE BESYLATE 369 332 4 6
NAMENDA 344 318 5 37
WARFARIN SODIUM 300 295 6 13
FUROSEMIDE 240 236 7 8
DONEPEZIL HCL 234 214 8 28
LIDODERM 200 193 9 80
HYDROCODONE-ACETAMINOPHEN 198 146 S3 10 1
CITALOPRAM HBR 196 190 11 18
GLIPIZIDE 182 164 12 51
LEVOTHYROXINE SODIUM 176 157 13 4
HYDROCHLOROTHIAZIDE 165 131 14 10
ALBUTEROL SULFATE 150 126 15 93
ATORVASTATIN CALCIUM 145 127 16 19
FLUTICASONE PROPIONATE 130 115 17 31
LEVETIRACETAM 121 58 18 96
ESCITALOPRAM OXALATE 119 103 19 73
LANTUS 115 82 20 40
MIRTAZAPINE 114 107 21 52
RISPERIDONE 112 96 22 65
CARVEDILOL 111 97 23 26
TRAZODONE HCL 108 99 24 46
SPIRIVA 105 105 25 45
GABAPENTIN 102 87 26 12
HYDRALAZINE HCL 102 70 26 85
RANITIDINE HCL 101 96 28 25
TAMSULOSIN HCL 97 90 29 30
OMEPRAZOLE 96 93 30 5
QUETIAPINE FUMARATE 92 89 31 66
LOSARTAN POTASSIUM 91 70 32 20
IPRATROPIUM BROMIDE 75 68 33 164
ACETAMINOPHEN-CODEINE 74 71 S3 34 60
SODIUM CHLORIDE 73 68 35 256
METOPROLOL SUCCINATE 72 56 36 17
NOVOLOG 71 51 37 89
PREDNISONE 69 69 38 34
METFORMIN HCL 68 64 39 7
ISOSORBIDE MONONITRATE ER 66 54 40 38
CIPROFLOXACIN HCL 65 50 41 59
BACLOFEN 60 51 42 101
DIVALPROEX SODIUM 58 38 43 81
ENOXAPARIN SODIUM 58 57 43 267
KLOR-CON M20 55 55 45 86
ATENOLOL 52 49 46 11
TRAVATAN Z 51 51 47 228
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.